Radiopharm Theranostics Ltd
RADX · XNASCIK 1949257fmd_0CTY5B4NBYMSDYZTQTV72NZF1ZManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2022 to Jun 30, 2026, 4 periods
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total revenues | 0 | 0 | 4 |
| Cost of revenue | – | – | 4 |
| Gross profit | 0 | 0 | 0 |
| Research and development | 23 | 23 | 28 |
| Operating income | (34) | (47) | (38) |
| Interest expense | 0 | 1 | 0 |
| Income before taxes | (35) | (48) | (38) |
| Income tax expense | 0 | 0 | 0 |
| Net income from continuing operations | (35) | (48) | (38) |
| Net income | (35) | (48) | (38) |